Dear Colleagues and Friends,

It is our pleasure to invite you to participate in The 4th International Annual Congress on Controversies on Cannabis-Based Medicines (Med-Cannabis2023) which will take place 4-5 December 2023 in Frankfurt, Germany.

Med-Cannabis2023 will address the many controversies surrounding cannabis-based medicines. Strong public and patient demand has led to the decision to allow cannabis products for medical use in most European countries. There is a lot of basic-science and clinical research on the potential use of cannabis products for chronic pain and cancer management as well as controversies on the potential harms.

This Congress will bring together physicians, researchers, clinicians, trialists, methodologists, industry professionals, the European Monitoring Centre for Drugs and Drug Addiction, and national cannabis agencies to update the current state of knowledge and of controversies and to outline some visions of the potential of cannabis-based medicines.

The program will include a wealth of knowledge from our world-renowned panel of experts. We look forward to seeing you at Med-Cannabis2023 in Frankfurt.


Dr. Silviu Brill
Tel Aviv Medical Center, Israel
Congress Co-Chair
Prof. David Finn
University of Galway, Ireland
Congress Co-Chair